Suppr超能文献

采用辅助治疗和顺铂类治疗提高头颈癌的治疗比率。

Improving therapeutic ratio in head and neck cancer with adjuvant and cisplatin-based treatments.

作者信息

Marcu Loredana G

机构信息

School of Chemistry and Physics, University of Adelaide, Adelaide, SA 5000, Australia ; Faculty of Science, University of Oradea, 410087 Oradea, Romania.

出版信息

Biomed Res Int. 2013;2013:817279. doi: 10.1155/2013/817279. Epub 2013 Dec 19.

Abstract

Advanced head and neck cancers are difficult to manage despite the large treatment arsenal currently available. The multidisciplinary effort to increase disease-free survival and diminish normal tissue toxicity was rewarded with better locoregional control and sometimes fewer side effects. Nevertheless, locoregional recurrence is still one of the main reasons for treatment failure. Today, the standard of care in head and neck cancer management is represented by altered fractionation radiotherapy combined with platinum-based chemotherapy. Targeted therapies as well as chronotherapy were trialled with more or less success. The aim of the current work is to review the available techniques, which could contribute towards a higher therapeutic ratio in the treatment of advanced head and neck cancer patients.

摘要

尽管目前有大量的治疗手段,但晚期头颈癌仍难以治疗。为提高无病生存率和减少正常组织毒性而进行的多学科努力,带来了更好的局部区域控制,且有时副作用更少。然而,局部区域复发仍然是治疗失败的主要原因之一。如今,改变分割放疗联合铂类化疗是头颈癌治疗的标准护理方式。靶向治疗以及时间治疗法都进行了试验,或多或少取得了一些成功。当前这项工作的目的是回顾现有的技术,这些技术有助于在晚期头颈癌患者的治疗中提高治疗增益比。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd14/3881661/b295fcc44d2b/BMRI2013-817279.001.jpg

相似文献

1
Improving therapeutic ratio in head and neck cancer with adjuvant and cisplatin-based treatments.
Biomed Res Int. 2013;2013:817279. doi: 10.1155/2013/817279. Epub 2013 Dec 19.
2
Overview of platinum chemotherapy in head and neck cancer.
Semin Oncol. 1994 Oct;21(5 Suppl 12):20-7.
5
Low-dose weekly platinum-based chemoradiation for advanced head and neck cancer.
Laryngoscope. 2010 Feb;120(2):236-42. doi: 10.1002/lary.20536.
6
8
Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer.
N Engl J Med. 1998 Jun 18;338(25):1798-804. doi: 10.1056/NEJM199806183382503.
9
Impact of tumor control and presence of visible necrosis in head and neck cancer patients treated with radiotherapy or radiochemotherapy.
J Cancer Res Clin Oncol. 2005 Nov;131(11):758-64. doi: 10.1007/s00432-005-0018-z. Epub 2005 Nov 1.
10
Neo-adjuvant chemotherapy with cisplatin and short infusional 5-FU in advanced head and neck malignancies.
J Cancer Res Ther. 2005 Jan-Mar;1(1):46-50. doi: 10.4103/0973-1482.16091.

引用本文的文献

3
MR-Guided Adaptive Radiotherapy for OAR Sparing in Head and Neck Cancers.
Cancers (Basel). 2022 Apr 10;14(8):1909. doi: 10.3390/cancers14081909.
5
RKIP promotes cisplatin-induced gastric cancer cell death through NF-κB/Snail pathway.
Tumour Biol. 2015 Mar;36(3):1445-53. doi: 10.1007/s13277-014-2496-6. Epub 2014 Dec 30.
6
Differential diagnostics of pain in the course of trigeminal neuralgia and temporomandibular joint dysfunction.
Biomed Res Int. 2014;2014:563786. doi: 10.1155/2014/563786. Epub 2014 Jun 4.

本文引用的文献

4
Cancer statistics, 2013.
CA Cancer J Clin. 2013 Jan;63(1):11-30. doi: 10.3322/caac.21166. Epub 2013 Jan 17.
6
Mitaplatin increases sensitivity of tumor cells to cisplatin by inducing mitochondrial dysfunction.
Mol Pharm. 2012 Mar 5;9(3):634-44. doi: 10.1021/mp200571k. Epub 2012 Feb 13.
8
The role of PET imaging in overcoming radiobiological challenges in the treatment of advanced head and neck cancer.
Cancer Treat Rev. 2012 May;38(3):185-93. doi: 10.1016/j.ctrv.2011.06.003. Epub 2011 Jul 13.
10
Effect of amifostine on survival among patients treated with radiotherapy: a meta-analysis of individual patient data.
J Clin Oncol. 2011 Jun 20;29(18):2590-7. doi: 10.1200/JCO.2010.33.1454. Epub 2011 May 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验